Compare Sunbelt Rentals Holdings Inc. Common Stock (SUNB) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sunbelt Rentals Holdings Inc. Common Stock vs Tango Therapeutics Inc. — how do they compare? Sunbelt Rentals Holdings Inc. Common Stock trades at $74.7 (market cap $31.69B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.75B). The key difference: Sunbelt Rentals Holdings Inc. Common Stock is far larger — about 8.5× Tango Therapeutics Inc.'s market cap, and Sunbelt Rentals Holdings Inc. Common Stock pays a 1.36% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sunbelt Rentals Holdings Inc. Common Stock for 6 Days and Tango Therapeutics Inc. for 0 Days on average.
| SUNB | TNGX | |
|---|---|---|
Market Cap | $31.69B | $3.75B |
Volume | 3,330,792 | 9,619,106 |
Sector | Industrials | Health |
52-Week High | $86.06 | $32.90 |
52-Week Low | $63.09 | $7.50 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $43.08B | $2.77B |
Dividend Yield | 1.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SUNB trades at $77.33, up 2.34% with neutral technical signals. The company reported strong Q2 2026 earnings beat ($1.18 vs $0.99 expected) and raised FY2027 guidance. Valuation metrics show P/E of 23.08 and ROE of 18.37%, with revenue growth from $10.79B to $11.5B projected. Recent institutional buying includes State Street Corp's $441M investment in Q2 2026.
Outlook remains positive with analyst consensus target of $86.83 (12.3% upside). Key opportunities include infrastructure demand and specialty equipment rental growth, while risks involve significant debt load ($7.5B) and declining free cash flow. The stock presents a balanced risk-reward profile with moderate growth potential.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Sunbelt Rentals Holdings Inc. Common Stock
Sunbelt Rentals provides equipment rentals and related services in the United States, Canada, and the United Kingdom. Its fleet includes general and specialty equipment for construction, industrial, infrastructure, and maintenance projects.
Read more on SUNB →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
